Release Date: 02/03/15 08:28 Summary: Appendix 4E 2014 Unaudited Preliminary Final Report Price Sensitive: Yes Download Document 803.42KB Download
Webinar: What investors should know about what it takes for ASX-listed companies to get medical developments to market